• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Model Number S-60-060-120-P6
Medical Device Problem Codes Material Separation (1562); Difficult or Delayed Activation (2577); Material Deformation (2976)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/17/2021
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the procedure was performed to treat a target lesion in the right common femoral artery.The supera stent delivery system was advanced to the target lesion, and an attempt was made to deploy stent in the right common femoral artery; however, the stent would not release.The physician finally was able to get the stent to release; however, the proximal end twisted about 180 degrees.Two non-abbott stents were then deployed, with one of the stents implanted overlapping the supera, to fully expand the stent at the location it was twisted.During removal of the delivery system, the physician was aggressive and the delivery catheter separated.All portions of the device were able to be removed without any additional intervention.There was no adverse patient effect and no clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history of the reported lot revealed no other incidents reported from this lot.The investigation determined the reported difficulties resulting in unexpected medical intervention were likely due to circumstances of the procedure.It is likely that the distal sheath of the delivery system was entrapped or bent in the anatomy (possibly at the aortic bifurcation) such that the ratchet was unable to properly engage the stent resulting in difficulty deploying.Additionally, the material deformation of the stent was likely the result of the delivery system being twisted and torqued to fully release the stent.Reportedly, the shaft separation occurred due to aggressive removal of the delivery system.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Additional Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history of the reported lot revealed no other incidents reported from this lot.The investigation determined the reported difficulties resulting in unexpected medical intervention were likely due to circumstances of the procedure.It is likely that the distal sheath of the delivery system was entrapped or bent in the anatomy (possibly at the aortic bifurcation) such that the ratchet was unable to properly engage the stent resulting in difficulty deploying.Additionally, the material deformation of the stent was likely the result of the delivery system being twisted and torqued to fully release the stent.Reportedly, the shaft separation occurred due to aggressive removal of the delivery system.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Event or Problem Description
It was reported that the procedure was performed to treat a target lesion in the right common femoral artery.The supera stent delivery system was advanced to the target lesion, and an attempt was made to deploy stent in the right common femoral artery; however, the stent would not release.The physician finally was able to get the stent to release; however, the proximal end twisted about 180 degrees.Two non-abbott stents were then deployed, with one of the stents implanted overlapping the supera, to fully expand the stent at the location it was twisted.During removal of the delivery system, the physician was aggressive and the delivery catheter separated.All portions of the device were able to be removed without any additional intervention.There was no adverse patient effect and no clinically significant delay in the procedure.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Common Device Name
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key13211805
Report Number2024168-2022-00324
Device Sequence Number1533964
Product Code NIP
UDI-Device Identifier08717648211805
UDI-Public08717648211805
Combination Product (Y/N)N
Initial Reporter StateNC
Initial Reporter CountryUS
PMA/510(K) Number
P120020
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 01/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/28/2023
Device Model NumberS-60-060-120-P6
Device Catalogue NumberS-60-060-120-P6
Device Lot Number1033061
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 12/17/2021
Initial Report FDA Received Date01/10/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured03/30/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-